Krystal Biotech Inc (NASDAQ:KRYS)
| 82.87 Delayed Data As of Jan 30 |  -1.43 / -1.70%Today’s Change | 47.67 Today|||52-Week Range 85.65 | +4.61% Year-to-Date |
Latest KRYS News | Press Releases
No recent news for Krystal Biotech Inc.
Today’s Trading
| Previous close | 84.22 |
| Today’s open | 83.82 |
| Day’s range | 81.51 - 84.65 |
| Volume | 93,707 |
| Average volume (3 months) | 173,202 |
| Market cap | $2.2B |
Data as of 3:59pm ET, 01/30/2023
Growth & Valuation
| Earnings growth (last year) | -83.05% |
| Earnings growth (this year) | -72.72% |
| Earnings growth (next 5 years) | -22.67% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SUPNSupernus Pharmaceuti... | +0.45 | +1.11% |
| TGTXTG Therapeutics Inc | -0.13 | -0.89% |
| ---- | ||
| ---- |
Data as of 4:00pm ET, 01/30/2023
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$1.26 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$69.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pittsburgh, Pennsylvania |
Forecasts
